Novel drug delivery carrier: Resealed erythrocytes

International Journal of Pharma and Bio Sciences

Volumn 2, Issue 1, 2011, Pages 394-406

  Shah, Shashank ^a  

^a Central India Institute of Pharmacy   (India)

Author keywords

Biodegradability; Cancer; Carrier; Resealed erythrocyte; Steroid

Indexed keywords

ACETYLSALICYLIC ACID; ARGINASE; BETA GALACTOSIDASE; BRINASE; CYTOSINE; DAUNORUBICIN; DEFEROXAMINE; DRUG CARRIER; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEPARIN; LUCIFERASE; METHOTREXATE; RECOMBINANT INTERLEUKIN 2; RUBOMYCIN; UREASE;

ARTICLE; BIODEGRADABILITY; BIOREACTOR; BLOOD SAMPLING; CELL ISOLATION; CELL STRUCTURE; CENTRIFUGATION; CYTOLYSIS; DIALYSIS; DILUTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; ERYTHROCYTE; ERYTHROCYTE SEDIMENTATION RATE; HEMOLYSIS; HUMAN; HYPO OSMOTIC LYSIS; HYPOTONIC DIALYSIS; HYPOTONIC DILUTION; IN VITRO STUDY; ISOTONIC OSMOTIC LYSIS; NONHUMAN; OSMOTIC STRESS; PLASMA; PRESWELL DILUTIONAL HEMOLYSIS; RESEALED ERYTHROCYTE;

EID: 84855314217     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Adrianenseen k., Karcher D., Lonwenthal A. and Terheggen H.G. Clinical chemistry vol 22, 323 (1976).
2. R. Green and K.J.Widder, Methods in Enzymology (Academic Press, San Diego, (1987),pp149.
3. G.J. Tortara B. Derrickson, The Cardiovascular System The Blood in Principles of Anatomy and Physiology,669-672
4. Berman J.D. and Alkawa M. Am. J. Trop. Med. Hyg.33,1112. (1984)
5. Baker R.F. and Gills N.R., Blood 33,170. (1969)
6. Bax B.E., Bin M.D.,Talbot P.J., Parker Williams E.J. and Chalmers R.A. (1999) Clinical science.96,171.
7. Patel R.P., Patel M.J., Patel N.A., An Overview of Resealed Erythrocyte Drug Delivery, Journal of Pharmacy Research 2009, 2(6),1008-1012
8. Gothoskar A.V., Resealed Erythrocytes: A Review, Pharmaceutical Technology, March 2004, 140-158.
9. Billah M.M, Finen J.B., Colfman R. and Michell R.H. (1976),biochem biophys acia 433,54.
10. D.A. Lewis and H.O. Alpar, (1984)."Therapeutic Possibilities of Drugs Encapsulated in Erythrocytes," Int. J. Pharm. 22, 137-146
11. U. Zimmermann, Cellular Drug-Carrier Systems and Their Possible Targeting In Targeted Drugs, EP Goldberg, Ed. (John Wiley & Sons, New York, 1983),153-200.
12. S.P. Vyas and R.K. Khar, Resealed Erythrocytes in Targeted and Controlled Drug Delivery: Novel Carrier Systems (CBS Publishers and Distributors, India, 2002), 87-416.
13. H.C. Eichler et al (1987), "In Vitro Drug Release From Human Carrier Erythrocytes," Adv. Biosci. (series) 67, 11- 15
14. M.P. Summers (1983), "Recent Advances in Drug Delivery," Pharm. J. 230, 643-645.
15. Carmen Gutierrez Millan, Maria Luisa Sayalero Marinero, Aranzazu Zarzuelo Castaneda and Jose M. Lanao, Drug, enzyme and peptide delivery using erythrocytes as carriers, Journal of Controlled Release,95(1), 2004, 27-49
16. Mehrdad Hamidi, Adbolhossein Zarrina, Mahshid Foroozesha and Soliman Mohammadi-Samania (2007),Applications of carrier erythrocytes in delivery of biopharmaceuticals, Journal of Controlled Release,118(2),, 145-160
17. D.A.Tyrrell, B.E.Ryman, Encapsulation of PEG-Urease/PEG-AlaDH Within Sheep Erythrocytes and Determination of the System's Activity in Lowering Blood Levels of Urea in Animal Models, biochemistry soc.trans., 1976,4, 677.
18. J.R.DeLoach, G.M.Ihler, Carrier Erythrocyte, Biochem. Biophys. Acta., 1979, 496:136
19. R.Goldman, T.Facchinetti, D.Bach, A.Raz, M. Shintizky, Activation of Phospholipase A2 by Adriamycin in vitro. Role of Drug- Lipid Interactions Biochem. Biophys. Acta, 1979, 512:254.
20. M. Hamidi and H.tajerzadeh, Carrier Erythrocyte an Overview, Drug Delivery, 2003, 10, 9-20
21. R. L. Lopez-Marques, L. R. Poulsen, S. Hanisch, K. Meffert, M. J. Buch-Pedersen, M. K. Jakobsen, T. G. Pomorski, and M. G. Palmgren, Intracellular Targeting Signals and Lipid Specificity Determinants of the ALA/ALIS P4-ATPase Complex Reside in the Catalytic ALA {alpha}-SubunitMol. Biol. Cell 2010 21:791-801
22. X. Zhou and T. R. Graham, Reconstitution of phospholipid translocase activity with purified Drs2p, a type-IV P-type ATPase from budding yeastProc. Natl. Acad. Sci. USA 2009 106:16586-16591
23. U. Zimmermann, Jahresbericht der Kernforschungsanlage Julich GmbH (Nuclear Research Center, Julich, 1973), pp. 55-58
24. M. Hamidi and H. Tajerzadeh, "Carrier Erythrocytes: An Overview," Drug Delivery 10, 9-20 (2003).
25. G.M. Ihler and H.C.W. Tsang, "Hypotonic Hemolysis Methods For Entrapment of Agents in Resealed Erythrocytes," Methods Enzymol. (series) 149, 221- 229 (1987)
26. J.R. Deloach, R.L. Harris, and G.M. Ihler, "An Erythrocyte Encapsu-Pharmaceutical Technology MARCH 2004 155,156
27. G.M. Ihler,"Erythrocyte Carriers,"Pharmacol. Ther. 20, 151-169 (1983).
28. S. Jain and N.K. Jain, "Engineered Erythrocytes as a Drug Delivery System," Indian J. Pharm. Sci. 59, 275- 281 (1997).
29. M.Magnani et al., Biotechnol. Appl. Biochem. 28, 1-6 (1998)
30. Castro, Massimo; Knafelz, Daniela, Periodic Treatment with Autologous Erythrocytes Loaded with Dexamethasone 21-Phosphate for Fistulizing Pediatric Crohn's Disease: Case Report, Journal of Pediatric Gastroenterology and Nutrition: 2006 42(3) 313-315
31. Maria Irene; Papadatou, Bronislava, Periodic Treatment with Autologous Erythrocytes Loaded with Dexamethasone 21-Phosphate for Fistulizing Pediatric Crohn's Disease: Case Report, Journal of Pediatric Gastroenterology and Nutrition: 2006,42 (3)313-315
32. Rossi, Luigia; Ambrosini, Periodic Treatment with Autologous Erythrocytes Loaded with Dexamethasone 21-Phosphate for Fistulizing Pediatric Crohn's Disease: Case Report, Journal of Pediatric Gastroenterology and Nutrition: 2006 42 (3)313-315
33. Mambrini, Giovanni; Periodic Treatment with Autologous Erythrocytes Loaded with Dexamethasone 21-Phosphate for Fistulizing Pediatric Crohn's Disease: Case Report, Journal of Pediatric Gastroenterology and Nutrition: 2006 42 (3)313-315
34. Magnani, Mauro, Periodic Treatment with Autologous Erythrocytes Loaded with Dexamethasone 21-Phosphate for Fistulizing Pediatric Crohn's Disease: Case Report, Journal of Pediatric Gastroenterology and Nutrition: 2006, 42(3) 313-315
35. V. Jaitely et al., "Resealed Erythrocytes: Drug Carrier Potentials andBiomedical Applications," Indian Drugs 33, 589-594 (1996).
36. E. Pitt et al., "Encapsulation of Drugs in Intact Erythrocytes: An Intravenous Delivery System," Biochem. Pharmacol. 22, 3359- 3368 (1983).
37. J.R. Deloach and G.M. Ihler, "A Dialysis Procedure for Loading of Erythrocytes with Enzymes and Lipids," Biochim. Biophys. Acta. 496, 136-145 (1977).
38. N. Talwar and N.K. Jain, "Erythrocytes as Carriers of Metronidazole: In-Vitro Characterization," Drug Dev. Ind. Pharm. 18, 1799-1812 (1992).
39. K.Adriaenssens et al., "Use of Enzyme-Loaded Erythrocytes in In Vitro Correction of Arginase Deficient Erythrocytes in Familiar Hyperargininemia," Clin. Chem. 22, 323-326 (1976).
40. H.O.Alpar and D.A. Lewis, "Therapeutic Efficacy of Asparaginase Encapsulated in Intact Erythrocytes," Biochem. Pharmacol. 34, 257-261 (1985).
41. M.C. Rechsteiner, "Uptake of Protein by Red Cells," Exp. Cell Res. 43, 487-492 (1975).
42. W.N. Field, M.D. Gamble, and D.A. Lewis, "A Comparison of Treatment of Thyroidectomized Rats with Free Thyroxin and Thyroxin Encapsulated in Erythrocytes," Int. J. Pharm. 51, 175- 178 (1989).
43. H. Tajerzadeh and M. Hamidi, "Evaluation of the Hypotonic Preswelling Method for Encapsulation of Enalaprilat in Human Intact Erythrocytes," Drug Dev. Ind. Pharm. 26,1247-1257(2000)
44. J. Bird, R. Best, and D.A. Lewis, "The Encapsulation of Insulin in Erythrocytes,"J. Pharm. Pharmacol. 35, 246-247 (1983).
45. S. Jain, S.K. Jain, and V.K. Dixit, "Magnetically Guided Rat Erythrocytes Bearing Isoniazid: Preparation, Characterization, and Evaluation," Drug Dev. Ind. Pharm. 23, 999-1006 (1997).
46. E. Pitt, D.A. Lewis, and R. Offord, "The Use of Corticosteroids Encapsulated in Erythrocytes in the Treatment of Adjuvant Induced Arthritis in the Rat," Biochem. Pharmacol. 132, 3355-3358 (1983).
47. G.L. Dale, D.G.Villacorte, and E. Beutler, "High Yield Entrapment of Protein into Erythrocytes," Biochem.Med. 18, 220-225 (1977).
48. C. Klibansky, PhD, thesis, Hebrew University, Jerusalem, Israel (1959).
49. R. Kravtozoff et al., "Erythrocytes as Carriers for L-Asparaginase: Methodological and Mouse In-Vivo Studies," J. Pharm. Pharmacol. 42, 473- 476 (1990).
50. M. Jrade et al.,"Rheological Approach to Human Red Blood Cell Carriers Desferrioxamine Encapsulation," Adv. Biosci. (series) 67, 29-36 (1987).
51. J.D. Berman,"Antileishmanial Activity of Red Cell Encapsulated Drugs," Adv. Biosci. (series) 67, 145-152 (1987).
52. J.R. Deloach et al., "Subcutaneous Administration of [35-S] r-IL-2 in Mice Carrier Erythrocytes: Alteration of IL-2 Pharmacokinetics," Adv. Biosci. (series) 67, 183-190 (1987).
53. J.R. Deloach and R. Doleskey, "Preparation and Properties of Microcytic Carrier Erythrocytes from Sheep and Goats," Adv. Biosci. (series) 67, 199-212 (1987).
54. A. Zanella et al., "Desferrioxamine Loading of Red Cells for Transfusion," Adv. Biosci. (series) 67, 17-27 (1987).
55. G. Fiorelli et al., "Transfusion of Thalasemic Patients with Desferrioxamine Loaded Standard Red Blood Cell Units," Adv. Biosci. (series) 67, 47-54 (1987).
56. M.C. Villareal et al., "Approach to Optimization of Inositol Hexaphosphate Entrapment into Human Red Blood Cells," Adv. Biosci. (series) 67, 55-62 (1987).
57. C. Hurel et al., "Optimization of Desferrioxamine Loading in Red Blood Cells," Adv. Biosci. (series) 67, 37-46 (1987).
58. M.C. Villareal et al., "Modification of Cardiac Parameters in Piglets After Infusion of IHPLoaded Red Blood Cells," Adv. Biosci. (series)67, 81-88 (1987)
59. B. Deuticke, M. Kim, and C. Zolinev, "The Influence of Amphotericin-B on the Permeability of Mammalian Erythrocytes to Nonelectrolytes, anions and Cations," Biochim. Biophys. Acta. 318, 345-359 (1973).
60. T. Kitao, K. Hattori, and M. Takeshita, "Agglutination of Leukemic Cells and Daunomycin Entrapped Erythrocytes with Lectin In Vitro and In Vivo," Experimentia 341, 94-95 (1978).
61. W. Lin et al.,"Nuclear Magnetic Resonance and Oxygen Affinity Study of Cesium Binding in Human Erythrocytes," Arch Biochem Biophys. 369, (1) 78-88 (1999).
62. K. Kinosita and T.Y. Tsong, "Hemolysis of Human Erythrocytes by a Transient Electric Field," Proc. Natl. Acad. Sci. USA 74, 1923-1927 (1977).
63. U. Zimmermann, F. Riemann, and G. Pilwat, "Enzyme Loading of Electrically Homogenous Human Red Blood Cell Ghosts Prepared by Dielectric Breakdown," Biochim. Biophys. Acta. 436, 460-474 (1976).
64. N. Talwar and N.K. Jain,"Erythrocytes as Carriers of Primaquin Preparation: Characterization and Evaluation," J. Controlled Release 20, 133-142 (1992).
65. M.I. Garin et al., "Erythrocytes as Carriers for Recombinant Human Erythropoietin," Pharm. Res. 13, 869- 874 (1996)
66. S. Jain, S.K. Jain, and V.K. Dixit, "Erythrocytes Based Delivery of Isoniazid: Preparation and In Vitro Characterization," Indian Drugs 32, 471- 476 (1995).
67. M. Hamidi et al., "In Vitro Characterization of Human Intact Erythrocytes Loaded by Enalaprilat," Drug Delivery 8, 231-237 (2001).
68. S.J. Updike and R.T.Wakamiya, "Infusion of Red Blood Cell-Loaded Asparaginase in Monkey," J. Lab. Clin.Med. 101, 679-691 (1983).
69. G.M. Iher, R.M. Glew, and F.W. Schnure, "Enzyme Loading of Erythrocytes," Proc. Natl. Acad. Sci. USA 70, 2663-2666 (1973).
70. Vyas s. P.; Naresh Talwar; Karajgi J. S.; Jain N. K., An erythrocyte based bioadhesive system for nasal delivery of propranolol, Journal of controlled release, 1993(23), 231-237
71. R Green, J Miller and W Crosby, Enhancement of iron chelation by desferrioxamine entrapped in red blood cell ghosts, The American Society of Hematology 57(5), 866-872
72. B C Pressman, Biological Applications of Ionophores, Annual Review of Biochemistry,(45) 501-530
73. U. Sprandel, A.R.Hubbard, and R.A. Chalmers, "In Vivo Life Span of Resealed Rabbit Erythrocyte 'Ghosts'," Res. Exp. Med. (Berl) 177 (1), 13-17. (1980).
74. S.K. Jain and S.P.Vyas,"Magnetically Responsive Diclofenac Sodium- Loaded Erythrocytes: Preparation and In Vitro Characterization, J. Microencapsul. 11 (2), 141-151 (1994).
75. G. Flynn, L. McHale, and A.P. McHale,"Methotrexate-Loaded, Photosensitized Erythrocytes: A Photo-Activatable Carrier/Delivery System for Use in Cancer Therapy," Cancer Lett. 82 (2), 225-229 (1994).
76. L. Chiarantini et al., "Modulated Red Blood Cell Survival by Membrane Protein Clustering," Mol. Cell Biochem. 144 (1), 53- 59 (1995).
77. Jaitely V.; Kanaujia P.; Venkatesan N.; Jain S.; Vyas S. P. Resealed erythrocytes: drug carrier potentials and biomedical applications, 1996, (33). 589-594
78. Gintautas Saulis, The loading of human erythrocytes with small molecules by electroporation, cellular & molecular biology letters 10 (2005) 23 - 35
79. J. Cuppoletti et al., "Erythrosomes: Large Proteoliposomes Derived from Cross-Linked Human Erythrocyte Cytoskeletons and Exogenous Lipid," Proc. Natl. Acad. Sci. USA 78 (5), 2786- 2790 (1981).
80. C.Y. Jung, Methods in Enzymology (Academic Press, New York, NY, 149- 217. (1987)
81. S.P. Vyas and V.K. Dixit, Pharmaceutical Biotechnology 1 (CBS Publishers & Distributors, New Delhi, 655.(1999)